resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
0d519727-94e9-4f9e-95d3-9227443c03fe,SW1990,['Cell Line'],The SW1990 cell line was used to establish a gemcitabine-resistant subline called SW1990-GZ by exposing the parental cells to increasing concentrations of gemcitabine over time.,['Drug resistance'],,,,https://doi.org/10.3892/ol.2019.10627
0d519727-94e9-4f9e-95d3-9227443c03fe,SW1990,['Cell Line'],The gemcitabine-resistant SW1990-GZ subline showed significantly lower sensitivity to gemcitabine compared to the parental SW1990 cells in an MTT viability assay.,"['Drug response', 'Cell viability']",,,,https://doi.org/10.3892/ol.2019.10627
0d519727-94e9-4f9e-95d3-9227443c03fe,SW1990,['Cell Line'],The SW1990 and SW1990-GZ cell lines exhibited distinct morphologies when observed under a microscope.,['Cell morphology'],,,,https://doi.org/10.3892/ol.2019.10627
0d519727-94e9-4f9e-95d3-9227443c03fe,SW1990,['Cell Line'],"The SW1990 cell line showed high expression levels of phosphorylated tyrosine sites on proteins like E-cadherin, DOK1, DLG1, ANXA2, and others compared to some other pancreatic cancer cell lines based on mass spectrometry analysis.","['Protein expression', 'Phosphorylation']",,,,https://doi.org/10.1074/mcp.M116.058313
